| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |